Pure Global

Inter Disciplinary Approach to Vocabulary Development in Hearing Impairment - Trial NCT04962828

Access comprehensive clinical trial information for NCT04962828 through Pure Global AI's free database. This phase not specified trial is sponsored by Riphah International University and is currently Recruiting. The study focuses on Hearing Impaired Children. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT04962828
Recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT04962828
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Inter Disciplinary Approach to Vocabulary Development in Hearing Impairment
The Effect Of An Inter Disciplinary Approach On Vocabulary Development in Children With Hearing Impairment; A Randomized Control Trial

Study Focus

Hearing Impaired Children

Vocabulary based intervention- Non Collaborative

Interventional

other

Sponsor & Location

Riphah International University

Kharian, Pakistan

Timeline & Enrollment

N/A

May 24, 2021

Jul 26, 2021

20 participants

Primary Outcome

Vocabulary List

Summary

The research aims to address to address the role of interdisciplinary working between
 professionals in the field of speech and language pathology/therapy. There is considerable
 evidence to state that when professionals work in collaboration with each other on particular
 goals that the outcomes are more favorable, functional and beneficial for the child.

ICD-10 Classifications

Hearing loss, unspecified
Other hearing loss
Other specified hearing loss
Family history of deafness and hearing loss
Congenital malformations of ear causing impairment of hearing

Data Source

ClinicalTrials.gov

NCT04962828

Non-Device Trial